{"transactions":[{"id":3170266,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":149670,"kind":"person","name":"Edwards Robert Grant","position":1,"cik":"0001810327","reported_name":"Edwards Robert Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-04-24T16:17:14.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":2609,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The award will vest in three years, with the first third vesting on April 14, 2021, second third will vest on April 14, 2022 and remaining third will vest on April 14, 2023. If the Issuer terminates Mr. Edwards prior to April 14, 2021, all stock will vest immediately on the termination date. If the Issuer terminates Mr. Edwards on or after April 14, 2021, including by not renewing this agreement, all unvested stock will be forfeited. If Mr. Edwards terminates, all unvested stock will be forfeited."}],"balance_after":2609,"source":{"system":"sec-edgar","filing":"0001683168-20-001273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810327/000168316820001273/ownership.xml","form_type":"4"}}]}